Scientists monitored for common concerns associated with growth hormone, such as changes in IGF-1 levels or insulin resistance, but found no significant issues
BPC 157 can be administered via injection, orally, or topically depending on the condition you're targeting
The process is discreet, convenient, and entirely managed through Edens digital platform
Gut Inflammation Given that BPC-157 is derived from the human gastric juice protein, there is particular interest in its potential for treating gut-related conditions, such as ulcers and inflammatory bowel disease (IBD, including Crohn's disease and ulcerative colitis)
Rationally designed combinatorial therapy is currently being investigated with chemotherapeutic drugs or immune checkpoint inhibitor therapies to improve the efficacy